What is Floreo?
Floreo operates at the intersection of behavioral health and immersive technology, providing a patented virtual reality platform designed to facilitate cognitive intervention. By utilizing VR headsets to simulate real-world scenarios, the company offers a controlled, interactive environment where users can practice social, communication, and daily living skills. This approach addresses a critical gap in traditional therapy by providing scalable, repeatable, and engaging experiences that are supervised by clinicians and caregivers. As a leader in the neurodiversity space, Floreo is transforming how therapeutic support is delivered, moving beyond conventional methods to leverage software-driven, data-informed outcomes for a historically underserved demographic.
How much funding has Floreo raised?
Floreo has raised a total of $10.3M across 3 funding rounds:
Debt
$150K
Debt
$156K
Series A
$10M
Debt (2020): $150K with participation from PPP
Debt (2021): $156K led by PPP
Series A (2022): $10M supported by Tenfore Holdings, Felton Group, The Disability Opportunity Fund, and The Autism Impact Fund
Key Investors in Floreo
Tenfore Holdings
A New York-based global investment firm specializing in growth-stage and middle-market opportunities, with a focus on sectors that drive innovation and resilience in the Fourth Industrial Revolution.
The Disability Opportunity Fund
A Nationally Certified CDFI dedicated to providing financial products and advisory services to improve the quality of life and economic mobility for individuals with disabilities.
The Autism Impact Fund
A specialized healthcare technology and innovation firm focused on investing in behavioral health, mental health, and neurodevelopmental disorder solutions.
What's next for Floreo?
The recent infusion of capital marks a pivotal transition for Floreo as it moves from early-stage development into a phase of rapid market penetration and product refinement. The company is expected to utilize these funds to enhance its library of virtual scenarios, strengthen its clinical partnerships, and broaden its distribution channels across healthcare and educational institutions. By focusing on outcomes-based care and the integration of AI-powered analytics, Floreo aims to solidify its position as the standard-bearer for digital therapeutics in the autism community. Future growth will likely center on increasing accessibility to its platform, ensuring that its life-changing technology reaches a global audience while maintaining the rigorous scientific standards that define its brand.
See full Floreo company page
